"Affymetrix and Incyte also are investigating possible future commercial agreements between the companies." Nice kiss & makeup -- wonder what the above means...
Friday December 21, 4:05 pm Eastern Time
Press Release
SOURCE: Incyte Genomics, Inc.
Affymetrix and Incyte Genomics Settle All Patent
Infringement Litigation
PALO ALTO, Calif. and SANTA CLARA, Calif., Dec. 21 /PRNewswire/ -- Incyte
Genomics, Inc. (Nasdaq: INCY - news), the leading genomics information company and
Affymetrix, Inc., (Nasdaq: AFFX - news) the leader in creating breakthrough tools for the
genomic revolution, today announced a comprehensive settlement of all existing infringement
litigation between the two companies. The first lawsuit involved several of Affymetrix
microarray-related patents (U.S. Patent Nos. 5,445,934, 5,744305, 5,800,992, 5,871,928,
6,040,193). The second lawsuit involved Incyte's RNA amplification patents (U.S. Patent Nos.
5,716,785, 5,891,636). The companies have agreed to cross-licenses under their respective
intellectual property portfolios. Financial terms were not disclosed. Affymetrix and Incyte also
are investigating possible future commercial agreements between the companies.
(snip) |
